Miller J, Streja E, Ricks J, Norris K, Nissenson A, Kovesdy C, Kalantar-Zadeh K. Examining Survival Benefits of Higher Doses of Paricalcitol in Hemodialysis Patients: Propensity Score Matching and Overadjustment… Read more
Van Wyck D, Robertson J, Provanzano R, Nissenson A, Levine R, Goykhman I, McAllister C. Higher Scores on a Weighted, Facility-specific Performance Measure Predict Mortality and Hospitalization in Hemodialysis Patients…. Read more
Kalantar-Zadeh K, Miller J, Streja E, Ricks J, Norris K, Nissenson A, Kovesdy C. Proposed Bundling System and Active Vitamin D Administration for African American Hemodialysis Patients. American Society of… Read more
Miller J, Ricks J, Streja E, Norris K, Nissenson A, Kovesdy C, Kalantar-Zadeh K. Higher Doses of Administered Paricalcitol is Associated with Greater 5-Year Survival in African American Hemodialysis Patients… Read more
Nissenson A, Showers M, Levine R. Hypertension and Fluid Dynamics in Patients Undergoing Short Daily versus Conventional Hemodialysis. American Society of Nephrology Renal Week. San Diego, CA, Oct 27 –… Read more
Noori N, Mehrotra R, Kopple J, Nissenson A, Kovesdy C and Kalantar-Zadeh K. Near-Infrared Measured Lean Body Mass in Correlated with Serum Creatinine in Long-Term Hemodialysis Patients. Cachexia Conference. Barcelona,… Read more
Streja E, Anker S, Mehrotra R, Kopple J, Nissenson A, Kovesdy C, Kalantar-Zadeh K. Serum Creatinine as a Surrogate of Muscle Mass and 5-Year Survival in over 130,000 Long-Term Hemodialysis… Read more
Wright S, Bogan A and Chokshi A. Nephrol News Issues. 2009;23(13):28-9. Read more
Khosravan R, Toh M, Garrett M, La Frague J, Ni G, Marbury T, Swan S, Lunde J, Bello C. J Clin Pharmacol. 2010;50(4):472-81. Read more
Chiu YW, Teitelbaum I, Misra M, de Leon EM, Adzize T and Mehrotra R. Clin J Am Soc Nephrol. 2009 Jun;4(6):1089-96. Read more